SHANNON WOODS: Open Payments
NPI 1730697517 · BARDSTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 63 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $982 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $232 |
| Amgen Inc. | 15 | $156 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $148 |
| Novo Nordisk Inc | 5 | $79 |
| PFIZER INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Lilly USA, LLC | 2 | $30 |
Products named: CAPLYTA, OTEZLA, VRAYLAR, UBRELVY, PREVNAR 20, QULIPTA, TRINTELLIX, Kerendia.
Industry payments across KY — which companies pay providers there.
